During the past decade, Exeter Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 17 clinical trials were completed, i.e. on average, 141.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Exeter Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Exeter Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Exeter Hospital" are "Prostate Cancer" (5 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "Breast Adenocarcinoma" (3 trials). Many other conditions were trialed in "Exeter Hospital" in a lesser frequency.

Most popular intervention types in "Exeter Hospital" are "Drug" (26 trials), "Other" (21 trials), "Radiation" (14 trials), "Biological" (13 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (8 trials), "Bevacizumab" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Exeter Hospital" are 22 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Exeter Hospital". undefined are not yet recruiting, 5 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Exeter Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Exeter Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Exeter Hospital has several departments that took part in Clinical trials: "Center for Cancer Care at Exeter Hospital" - 23 trials